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doi:10.1016/j.fjs.2011.09.001Summary Structural lesions are found in about 30% of patients who undergo epilepsy
surgery for intractable temporal lobe epilepsy. After detailed presurgical evaluations, the
concordance of semeiology, focal structural lesions, ictal and interictal epileptiform
discharges and neuropsychological dysfunction may offer favorable seizure control outcome
postoperatively. The temporal lobe structural lesions are classified by magnetic resonance
imaging-defined location into mesial temporal and lateral temporal (extrahippocampal)
groups. In the lateral temporal group, subdural grid and depth electrode implantation is
mandatory to localize the epileptic cortex and the possible secondary focus in the mesial
temporal structures. Different surgical strategies, such as lesionectomy alone, lesionectomy
with removal of adjacent epileptic cortex, lesionectomy with removal of mesiotemporal
structures, have variable seizure control outcomes. The underlying pathology and the
completeness of the lesion resection also affect the outcome.
Copyright ª 2011, Taiwan Surgical Association. Published by Elsevier Taiwan LLC. All rights
reserved.1. Introduction
The incidence of epilepsy ranges from 0.5% to 1.0% of the
total population. Approximately one-third of epileptic
patients have their seizures refractory to medical treat-
ment. About half of the medically intractable focal
epileptic patients are potential candidates for surgicall Institute, Taipei Veterans
ion 2, Shi-Pai Road, Taipei,
.tw.
ight ª 2011, Taiwan Surgical Assotreatment.1 Epilepsy surgery for intractable temporal lobe
epilepsy (TLE) with or without structural lesions usually
provides favorable surgical outcome. Structural lesions are
found in about 30% of surgical specimens resected for
intractable TLE.2,3 The proper evaluation of clinical
semeiology, focal structural lesions, interictal and ictal
electroencephalogram (EEG) abnormalities, and neuro-
psychological dysfunctions, especially when these factors
are in concordance, may help to offer good seizure control
postoperatively.4 The presence of a structural lesion in
a patient with intractable TLE does not always localize the
epileptogenic zone. The temporal lobe lesion can induceciation. Published by Elsevier Taiwan LLC. All rights reserved.
Table 1 Pathology in intractable TLE patients with
structural lesions
Lesion type No. of patients
Neoplastic group 82
Low-grade glioma 59
Astrocytoma 53
Oligodendroglioma 06
Anaplastic astrocytoma 08
DNET 03
Ganglioglioma 12
Vascular group 25
Arteriovenous malformation 11
Cavernous malformation 14
Lesional TLE/TLE Z 107/420 Z 25.5% (1987e2010 at Taipei
Veterans General Hospital).
DNET Z dysembryoplastic neuroectodermal tumor; TLE Z
temporal lobe epilepsy.
Figure 1 A 23-year-old male presented with intractable TLE
for 3 years. An ill-defined 3.8 cm lesion, involving the gray and
white matter of the left inferolateral midtemporal lobe, was
noted with high signal on the FSE T2-weighted images axial
MRI. Two subdural grids with 4  8 and 2  8 electrodes were
implanted in the left temporal lobe and covered the entire
lesion. A 4-contact depth electrode was implanted with the
first contact precisely located at the left hippocampal head.
FSE Z fast spin echo; MRI Z magnetic resonance imaging;
TLE Z temporal lobe epilepsy.
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tures. The incidence of an extrahippocampal lesion and
mesiotemporal sclerosis ranges from 8% to 22%.5e8
Different surgical strategies, such as lesionectomy alone
and lesionectomy with removal of mesiotemporal struc-
tures, have variable seizure control outcomes.9e12
2. Preoperative investigations
The preoperative investigations for intractable TLE consist
of serial EEG recordings, long-term EEG/video monitoring
with sphenoidal electrodes, magnetic resonance imaging
(MRI), magnetic resonance spectroscopy (MRS), positron
emission tomography with fluorodeoxyglucose (FDG-PET)
and neuropsychological assessment.13 MRI is the only
investigation that can distinguish between substrate-related
and substrate-unrelated epilepsy. An MRI-identified lesion is
a strong predictor of favorable seizure outcome following
surgery.14 The sensitivity of MRI in detecting the structural
lesions in refractory epileptic patients approaches 100%,
with a reported specificity of 87%.15 In our reported
series,13 MRI detected the lesion in all 12 patients in the
vascular group, and in all 12 patients with neoplasms other
than low grade astrocytomas in the neoplastic group.
However, MRI detected the lesions in only 61% (14/23) of
patients with low-grade astrocytomas. Won et al16 reported
that among MRI, PET and single photon emission comput-
erized tomography in lateralizing epileptogenic foci, PET
was the most sensitive tool which correctly lateralized
the focus in 85% of the patients. PET may be used as
a complementary tool in cases of inconclusive lateralization
with other presurgical evaluations. Detection of the func-
tion of the mesiotemporal structure before operation is
mandatory in the surgical strategy for lesional intractable
TLE. High resolution, thin-cut (3 mm) slices MRI with
a typical epilepsy protocol is recommended for the recog-
nition of hippocampal sclerosis.17 MRS can evaluate the
biochemical and metabolic condition of the brain tissue.
Reduction of the N-acetyl-aspartate (NAA) and decreased
ratio of NAA/creatine plus choline complex indicates rela-
tive dysfunction of the measured area. MRS can provide
evidence of hippocampal damage in a high percentage of
patients with TLE. An extrahippocampal lesion in combi-
nation with MRS evidence of hippocampal sclerosis (dual
pathology) can be found in up to 67% of patients with
temporal neocortical epilepsy.18
3. Surgical strategies
The goal of epilepsy surgery in treating intractable lesional
TLE is seizure freedom. It is necessary to remove the
structural lesion as well as the epileptogenic cortex while
preserving function. In Phase I preoperative investigations,
the epileptogenic focus of epileptic activity may not
correlate well with the abnormalities on MRI. Invasive
Phase II studies using subdural grids, depth electrode
implantation and intraoperative electrocorticography
(ECoG) are mandatory to localize seizure onset.19 A meta-
analysis of simple excision versus epilepsy surgery was
performed by Weber et al20 in 1993. The authors concluded
that in patients with lesional intractable seizures, epilepsysurgery had a better outcome of rendering the patient
seizure free.
In general, without consideration of the location of the
structural lesion, surgical strategies for intractable lesional
TLE include: (1) lesionectomy alone; (2) lesionectomy with
removal of the adjacent electrical abnormal cortex; (3)
lesionectomy with removal of the mesial temporal struc-
tures (dual pathology); (4) removal of the electrical
abnormal cortex alone; (5) anterior temporal lobectomy
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agation. The epileptogenic cortex can be defined by
epileptogenic discharges on intracranial ECoG or by the
ictal onset zone localized by invasive intracranial EEG.21
The completeness of the resection of the lesion, the
underlying pathology and the extent of the removal of the
associated epileptogenic cortex may affect the outcome of
intractable lesional TLE.Figure 2 (A) The electrocorticogram revealed independent interic
left hippocampus; (B) the ictal onset was initiated at the left hippoc
lesion.Lesionectomy is defined as surgical removal of the
structural lesion alone. However, pure lesionectomy is
difficult in surgical removal of the discrete lesions such as
cavernous malformations and arteriovenous malformations
(AVMs). The adjacent gliotic epileptogenic brain tissues
usually are removed during dissection and excision of the
lesion. By contrast, the infiltrative lesions, such as astro-
cytomas and gangliogliomas and developmental corticaltal spikes from the left lateral cortex around the lesion and the
ampus then spreading to the left lateral cortex surrounding the
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lesionectomy without removal of adjacent normal brain
tissue. When the lesion is inaccessible or located in an
eloquent cortex, the alternative approach is to remove the
epileptogenic cortex alone. Sometimes the lesion may be
regarded as unrelated to seizure onset.
Temporal lobe structural lesions can be classified as: (1)
developmental abnormalities including cortical dysplasia
and heterotopias; (2) vascular lesions including AVMs
and cavernous malformations; (3) tumors including astro-
cytomas, gangliogliomas and dysembryoplastic neuro-
ectodermal tumor (DNET); and (4) encephalomalacia due to
trauma or ischemia.22 In our unpublished series, there were
107 (25.3%) cases of lesional TLE out of 420 cases of
TLE operated upon in the period between 1987 and 2010
(Table 1). The structural lesions within the temporal
lobes are classified by the location defined by MRI into the
mesial temporal group and the lateral temporal (extra-
hippocampal) group. Different surgical strategies were
employed to maximize preservation of functionally intact
mesial structures in the treatment of epileptogenic mesial
and lateral temporal lobe lesions.23
The mesial temporal group patient usually presents with
mesial TLE (MTLE). MTLE is a well-defined clinical entity
with a characteristic semeiology, an EEG pattern and
pathological findings. Seizures usually consist of auras fol-
lowed by oral and/or gestural automatisms, and sometimes
secondary generalization. Some authors perform ATL,
which may or may not imply complete lesionectomy and
usually includes mesial structures. In most cases, ATL is
associated with good seizure control outcomes, and up to
80% of patients turn seizure-free.4,8e10,24 However, in terms
of maximal resection of the structural lesion and seizure
irritating zone while preserving hippocampal function,
several alternative surgical procedures have been advo-
cated.23 If the structural lesion is separated from mesial
structures on MRI and the hippocampus shows normal size
and function, the lesion is resected while preserving mesial
structures. In the nondominant hemisphere, mesial struc-
tures are removed despite a normal functioning hippo-
campus if the lesion is adjacent to or infiltrating the
hippocampus. However, more conservative procedures
should be considered in the dominant hemisphere.23
The lateral temporal (extrahippocampal) group patients
with a structural lesion located within the neocortex varies
in seizure characteristics. The neocortical temporal lobe
epilepsies (NTLE) often present with olfactory and gusta-
tory auras, complex gestures, ictal speech and secondary
generalizations.25 NTLE can be treated with a variety of
surgical strategies, and may include resection of mesial
temporal structures (dual pathology). Usui et al26 reported
the intracranial EEG findings in 15 patients with lesional
lateral TLE. They routinely implanted subdural grids
covering the lesion, and bilaterally placed depth electrodes
in the hippocampi and amygdalas to confirm the origin of
ictal discharges, and then decided upon the part of the
brain that should be excised. They concluded that
approximately 50% of the patients with structural lesions in
the lateral cortex showed independent epileptogenic areas
in ipsilateral mesial structures. Interictal spikes are not an
indicator of whether mesial structures should be resected.
In our institute, we implant a subdural grid covering thelesion and a depth electrode within the ipsilateral hippo-
campus (Figs. 1 and 2). The recordings of epileptiform
discharges from the subdural grid and depth electrode can
provide the information on ictal onset and the propagation
pathway. Some authors have adopted surgical strategies
using hippocampal atrophy on MRI as an indicator of
whether to include the mesial temporal structures in
surgical resection.5,8,11 However, long-term extraoperative
invasive intracranial EEG recording remains the most reli-
able method to confirm epileptogenicity.21 After confir-
mation, surgical strategies fall into three major groups: (1)
lesionectomy alone; (2) lesionectomy with removal of
adjacent epileptogenic cortex; and (3) lesionectomy with
removal of mesial temporal structures. If EEG recordings
are concordant with the lesion, lesionectomy alone will
result in a high rate of seizure freedom. Incomplete lesio-
nectomy and resection of electrically active cortex alone
seem less successful. The underlying pathology and extent
of removal of the associated epileptogenic cortex also
affect seizure control outcome.20,22
4. Conclusions
Seizure control outcomes for surgical treatment of lesional
intractable TLE vary widely. Good results have been re-
ported with lesionectomy alone (usually with removal of
the adjacent gliotic cortex) in discrete lesions such as
a cavernous malformation. The completeness of lesionec-
tomy in infiltrative lesions such as astrocytoma, ganglio-
glioma and DNET and developmental cortical anomaly such
as cortical dysplasia may alter the seizure control outcome
postoperatively. In TLE patients who present with dual
pathology, concomitant removal of mesial temporal struc-
tures helps to offer good surgical outcomes. With the
advancement of diagnostic techniques, previously indolent
lesions will become evident, and the seizure control
outcome will improve because of clear delineation of
lesions and the corresponding electrically abnormal cortex.
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